Miscellaneous

0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Polycythemia vera (Vaquez-Osler disease)-PCV-was first described in the year 1892 by Vaquez. Today the understanding is that PCV is a clonal neoplastic disease with the proliferation of erythrocytes. Together with chronic myelocytic leukemia, osteomyelofibrosis (OMF) and thrombocythemia, it is included in the group of myeloproliferative diseases (MPD). All the bone marrow elements (erythrocytes, megacaryocytes, granulocytes, and fibroblasts) are involved in the hyperplasia but erythropoiesis is the dominant factor. Also extramedullary hematopoiesis is possible. Hypervolemia, increased cardiac output, hyperviscosity and the resultant impaired blood flow are the reasons for most clinical manifestations. © 2007 Springer-Verlag Berlin Heidelberg.

Cite

CITATION STYLE

APA

Kropp, J. (2007). Miscellaneous. In Clinical Nuclear Medicine (pp. 519–535). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-28026-2_30

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free